Deep brain stimulation for obsessive-compulsive disorder: Systematic review and evidence-based guideline sponsored by the American society for stereotactic and functional neurosurgery and the congress of neurological surgeons (CNS) and endorsed by the CNS and American association of neurological surgeons

Clement Hamani, Julie Pilitsis, Anand I. Rughani, Joshua M. Rosenow, Parag G. Patil, Konstantin S. Slavin, Aviva Abosch, Emad N. Eskandar, Laura S. Mitchell, Steven Kalkanis

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

OBJECTIVE: To conduct a systematic review of the literature and develop evidencebased guidelines on DBS for OCD.

BACKGROUND: It is estimated that 40% to 60% of patients with obsessive-compulsive disorder (OCD) continue to experience symptoms despite adequate medical management. For this population of treatment-refractory patients, promising results have been reported with the use of deep brain stimulation (DBS).

METHODS: A systematic literature search was undertaken using the PubMed database for articles published between 1966 and October 2012 combining the following words: "deep brain stimulation and obsessive-compulsive disorder" or "electrical stimulation and obsessivecompulsive disorder." Of 353 articles, 7 were retrieved for full-text review and analysis. The quality of the articles was assigned to each study and the strength of recommendation graded according to the guidelines development methodology of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Guidelines Committee.

RESULTS: Of the 7 studies, 1 class I and 2 class II double-blind, randomized, controlled trials reported that bilateral DBS is more effective in improving OCD symptoms than sham treatment.

CONCLUSION: Based on the data published in the literature, the following recommendations can be made: (1) There is Level I evidence, based on a single class I study, for the use of bilateral subthalamic nucleus DBS for the treatment of medically refractory OCD. (2) There is Level II evidence, based on a single class II study, for the use of bilateral nucleus accumbens DBS for the treatment of medically refractory OCD. (3) There is insufficient evidence to make a recommendation for the use of unilateral DBS for the treatment of medically refractory OCD.

Original languageEnglish (US)
Pages (from-to)327-333
Number of pages7
JournalNeurosurgery
Volume75
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Deep Brain Stimulation
Obsessive-Compulsive Disorder
Neurosurgery
Guidelines
Subthalamic Nucleus
Nucleus Accumbens
Therapeutics
Neurosurgeons
PubMed
Electric Stimulation
Randomized Controlled Trials
Joints
Placebos
Databases
Population

Keywords

  • Deep brain stimulation
  • Guidelines
  • Neuromodulation
  • Obsessive-compulsive disorder
  • Psychiatry

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Medicine(all)

Cite this

Deep brain stimulation for obsessive-compulsive disorder : Systematic review and evidence-based guideline sponsored by the American society for stereotactic and functional neurosurgery and the congress of neurological surgeons (CNS) and endorsed by the CNS and American association of neurological surgeons. / Hamani, Clement; Pilitsis, Julie; Rughani, Anand I.; Rosenow, Joshua M.; Patil, Parag G.; Slavin, Konstantin S.; Abosch, Aviva; Eskandar, Emad N.; Mitchell, Laura S.; Kalkanis, Steven.

In: Neurosurgery, Vol. 75, No. 4, 01.01.2014, p. 327-333.

Research output: Contribution to journalReview article

@article{824bb2ed47da491882b5e9409db2858a,
title = "Deep brain stimulation for obsessive-compulsive disorder: Systematic review and evidence-based guideline sponsored by the American society for stereotactic and functional neurosurgery and the congress of neurological surgeons (CNS) and endorsed by the CNS and American association of neurological surgeons",
abstract = "OBJECTIVE: To conduct a systematic review of the literature and develop evidencebased guidelines on DBS for OCD.BACKGROUND: It is estimated that 40{\%} to 60{\%} of patients with obsessive-compulsive disorder (OCD) continue to experience symptoms despite adequate medical management. For this population of treatment-refractory patients, promising results have been reported with the use of deep brain stimulation (DBS).METHODS: A systematic literature search was undertaken using the PubMed database for articles published between 1966 and October 2012 combining the following words: {"}deep brain stimulation and obsessive-compulsive disorder{"} or {"}electrical stimulation and obsessivecompulsive disorder.{"} Of 353 articles, 7 were retrieved for full-text review and analysis. The quality of the articles was assigned to each study and the strength of recommendation graded according to the guidelines development methodology of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Guidelines Committee.RESULTS: Of the 7 studies, 1 class I and 2 class II double-blind, randomized, controlled trials reported that bilateral DBS is more effective in improving OCD symptoms than sham treatment.CONCLUSION: Based on the data published in the literature, the following recommendations can be made: (1) There is Level I evidence, based on a single class I study, for the use of bilateral subthalamic nucleus DBS for the treatment of medically refractory OCD. (2) There is Level II evidence, based on a single class II study, for the use of bilateral nucleus accumbens DBS for the treatment of medically refractory OCD. (3) There is insufficient evidence to make a recommendation for the use of unilateral DBS for the treatment of medically refractory OCD.",
keywords = "Deep brain stimulation, Guidelines, Neuromodulation, Obsessive-compulsive disorder, Psychiatry",
author = "Clement Hamani and Julie Pilitsis and Rughani, {Anand I.} and Rosenow, {Joshua M.} and Patil, {Parag G.} and Slavin, {Konstantin S.} and Aviva Abosch and Eskandar, {Emad N.} and Mitchell, {Laura S.} and Steven Kalkanis",
year = "2014",
month = "1",
day = "1",
doi = "10.1227/NEU.0000000000000499",
language = "English (US)",
volume = "75",
pages = "327--333",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Deep brain stimulation for obsessive-compulsive disorder

T2 - Systematic review and evidence-based guideline sponsored by the American society for stereotactic and functional neurosurgery and the congress of neurological surgeons (CNS) and endorsed by the CNS and American association of neurological surgeons

AU - Hamani, Clement

AU - Pilitsis, Julie

AU - Rughani, Anand I.

AU - Rosenow, Joshua M.

AU - Patil, Parag G.

AU - Slavin, Konstantin S.

AU - Abosch, Aviva

AU - Eskandar, Emad N.

AU - Mitchell, Laura S.

AU - Kalkanis, Steven

PY - 2014/1/1

Y1 - 2014/1/1

N2 - OBJECTIVE: To conduct a systematic review of the literature and develop evidencebased guidelines on DBS for OCD.BACKGROUND: It is estimated that 40% to 60% of patients with obsessive-compulsive disorder (OCD) continue to experience symptoms despite adequate medical management. For this population of treatment-refractory patients, promising results have been reported with the use of deep brain stimulation (DBS).METHODS: A systematic literature search was undertaken using the PubMed database for articles published between 1966 and October 2012 combining the following words: "deep brain stimulation and obsessive-compulsive disorder" or "electrical stimulation and obsessivecompulsive disorder." Of 353 articles, 7 were retrieved for full-text review and analysis. The quality of the articles was assigned to each study and the strength of recommendation graded according to the guidelines development methodology of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Guidelines Committee.RESULTS: Of the 7 studies, 1 class I and 2 class II double-blind, randomized, controlled trials reported that bilateral DBS is more effective in improving OCD symptoms than sham treatment.CONCLUSION: Based on the data published in the literature, the following recommendations can be made: (1) There is Level I evidence, based on a single class I study, for the use of bilateral subthalamic nucleus DBS for the treatment of medically refractory OCD. (2) There is Level II evidence, based on a single class II study, for the use of bilateral nucleus accumbens DBS for the treatment of medically refractory OCD. (3) There is insufficient evidence to make a recommendation for the use of unilateral DBS for the treatment of medically refractory OCD.

AB - OBJECTIVE: To conduct a systematic review of the literature and develop evidencebased guidelines on DBS for OCD.BACKGROUND: It is estimated that 40% to 60% of patients with obsessive-compulsive disorder (OCD) continue to experience symptoms despite adequate medical management. For this population of treatment-refractory patients, promising results have been reported with the use of deep brain stimulation (DBS).METHODS: A systematic literature search was undertaken using the PubMed database for articles published between 1966 and October 2012 combining the following words: "deep brain stimulation and obsessive-compulsive disorder" or "electrical stimulation and obsessivecompulsive disorder." Of 353 articles, 7 were retrieved for full-text review and analysis. The quality of the articles was assigned to each study and the strength of recommendation graded according to the guidelines development methodology of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Guidelines Committee.RESULTS: Of the 7 studies, 1 class I and 2 class II double-blind, randomized, controlled trials reported that bilateral DBS is more effective in improving OCD symptoms than sham treatment.CONCLUSION: Based on the data published in the literature, the following recommendations can be made: (1) There is Level I evidence, based on a single class I study, for the use of bilateral subthalamic nucleus DBS for the treatment of medically refractory OCD. (2) There is Level II evidence, based on a single class II study, for the use of bilateral nucleus accumbens DBS for the treatment of medically refractory OCD. (3) There is insufficient evidence to make a recommendation for the use of unilateral DBS for the treatment of medically refractory OCD.

KW - Deep brain stimulation

KW - Guidelines

KW - Neuromodulation

KW - Obsessive-compulsive disorder

KW - Psychiatry

UR - http://www.scopus.com/inward/record.url?scp=84924029159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924029159&partnerID=8YFLogxK

U2 - 10.1227/NEU.0000000000000499

DO - 10.1227/NEU.0000000000000499

M3 - Review article

C2 - 25050579

AN - SCOPUS:84924029159

VL - 75

SP - 327

EP - 333

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 4

ER -